Ledger.Open graph →

SEC Form D · Amendment · filed September 25, 2024

Hunterian Medicine LLC

Offering

—

Sold

$4.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Vinod Jaskula-Ranga · BALTIMORE, MDExec · Director Vinod Jaskula-Ranga · BALTIMORE, MDExec · Director Jeffrey Stevens · Toronto, Ontario, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗